<VariationArchive VariationID="3255365" VariationName="Single allele" VariationType="Deletion" Accession="VCV003255365" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2024-07-29" MostRecentSubmission="2024-07-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3414128" VariationID="3255365">
      <GeneList>
        <Gene Symbol="A-GAMMA3'E" FullName="A-gamma-globin 3' regulatory region" GeneID="109951028" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>11p15.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="5245527" stop="5248345" display_start="5245527" display_stop="5248345" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="BGLT3" FullName="beta globin locus transcript 3" GeneID="103344929" HGNC_ID="HGNC:49033" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>11p15.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="5244554" stop="5245546" display_start="5244554" display_stop="5245546" Strand="-" />
          </Location>
          <OMIM>616308</OMIM>
        </Gene>
        <Gene Symbol="HBE1" FullName="hemoglobin subunit epsilon 1" GeneID="3046" HGNC_ID="HGNC:4830" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>11p15.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="5268345" stop="5269945" display_start="5268345" display_stop="5269945" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="5289579" stop="5291372" display_start="5289579" display_stop="5291372" Strand="-" />
          </Location>
          <OMIM>142100</OMIM>
        </Gene>
        <Gene Symbol="HBG1" FullName="hemoglobin subunit gamma 1" GeneID="3047" HGNC_ID="HGNC:4831" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>11p15.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="5248269" stop="5249857" display_start="5248269" display_stop="5249857" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="5269501" stop="5271086" display_start="5269501" display_stop="5271086" Strand="-" />
          </Location>
          <OMIM>142200</OMIM>
        </Gene>
        <Gene Symbol="HBG2" FullName="hemoglobin subunit gamma 2" GeneID="3048" HGNC_ID="HGNC:4832" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>11p15.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="5253188" stop="5254781" display_start="5253188" display_stop="5254781" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="5274420" stop="5276010" display_start="5274420" display_stop="5276010" Strand="-" />
          </Location>
          <OMIM>142250</OMIM>
        </Gene>
        <Gene Symbol="HS-E1" FullName="beta-globin hypersensitive site-embryonic 1" GeneID="110740339" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>11p15.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="5266773" stop="5267519" display_start="5266773" display_stop="5267519" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC106099064" FullName="HBG1 recombination region" GeneID="106099064" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>11p15.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="5249068" stop="5250324" display_start="5249068" display_stop="5250324" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC106099065" FullName="HBG2 recombination region" GeneID="106099065" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>11p15.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="5253987" stop="5255252" display_start="5253987" display_stop="5255252" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC109951029" FullName="delta-globin 5' regulatory region" GeneID="109951029" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>11p15.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="5234433" stop="5239383" display_start="5234433" display_stop="5239383" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>Single allele</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11p15.4</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" innerStart="5235201" innerStop="5269140" display_start="5235201" display_stop="5269140" alternateAllele="-" />
      </Location>
      <Comment DataSource="MOLECULAR BIOLOGY AND HUMAN GENETICS DIVISION, THE UNIVERSITY OF BURDWAN" Type="public">the exact breakpoints at base resolution are not clear</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="Single allele AND Beta-thalassemia HBB/LCRB" Accession="RCV004595721" Version="1">
        <ClassifiedConditionList TraitSetID="80504">
          <ClassifiedCondition DB="MedGen" ID="CN322236">Beta-thalassemia HBB/LCRB</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2022-07-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-07-26" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-07-29" MostRecentSubmission="2024-07-29">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="80504" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="65989" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Beta-thalassemia HBB/LCRB</ElementValue>
                <XRef ID="MONDO:0013517" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Beta-thalassemia (Î²-thalassemia) is characterized by reduced synthesis of the hemoglobin subunit beta (hemoglobin beta chain) that results in microcytic hypochromic anemia, an abnormal peripheral blood smear with nucleated red blood cells, and reduced amounts of hemoglobin A (HbA) on hemoglobin analysis. Individuals with thalassemia major have severe anemia and hepatosplenomegaly; they usually come to medical attention within the first two years of life. Without treatment, affected children have severe failure to thrive and shortened life expectancy. Treatment with a regular transfusion program and chelation therapy, aimed at reducing transfusion iron overload, allows for normal growth and development and may improve the overall prognosis. Individuals with thalassemia intermedia present later and have milder anemia that does not require regular treatment with blood transfusion. These individuals are at risk for iron overload secondary to increased intestinal absorption of iron as a result of ineffective erythropoiesis.</Attribute>
                <XRef ID="NBK1426" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301599</ID>
                <ID Source="BookShelf">NBK1426</ID>
              </Citation>
              <XRef ID="CN322236" DB="MedGen" />
              <XRef ID="MONDO:0013517" DB="MONDO" />
              <XRef Type="MIM" ID="613985" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="9877402" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-29" DateCreated="2024-07-29">
        <ClinVarSubmissionID localKey=":Chr.11_5235201_5269140_-_Deletion|OMIM:613985" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV005088196" DateUpdated="2024-07-29" DateCreated="2024-07-29" Type="SCV" Version="1" SubmitterName="MOLECULAR BIOLOGY AND HUMAN GENETICS DIVISION, THE UNIVERSITY OF BURDWAN" OrgID="508651" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-07-26">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The variant causes long deletion in HBB;HBD; HBG1;HBG2 and HBE1 genomic region. When this variant present with another variant in HBB gene that causes severe anemia, patient require frequent transfusion in few cases Hepatosplenomegaly was observed</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>South east Asia</Ethnicity>
              <GeographicOrigin>India</GeographicOrigin>
              <Tissue>Blood</Tissue>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>16</NumberTested>
              <Gender>female</Gender>
              <FamilyData NumFamilies="16" NumFamiliesWithVariant="1">
                <FamilyHistory>yes</FamilyHistory>
              </FamilyData>
              <Indication Type="Indication">
                <Trait Type="Disease">
                  <Name>
                    <ElementValue Type="Preferred">Hemoglobinopathy</ElementValue>
                  </Name>
                </Trait>
              </Indication>
            </Sample>
            <Method>
              <NamePlatform>Illumina Miseq</NamePlatform>
              <TypePlatform>Target next-generation sequencing</TypePlatform>
              <Description>Targeted NGS of short arm of chr 11, beta globin gene cluster coordinate: 5223780 - 5304186paired end sequencing with 100x coverage in illumina MiSeq, CNV analysis was performed using CNVkit and further depth plot analysis, a long stretch of homozygous base call in VCF was the primary indication of long deletion</Description>
              <Software name="Illumina DRAGEN germline pipeline, CNVkit" purpose="CNV calling" />
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Read depth</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SecondaryFinding">no</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <Name>
                  <ElementValue Type="Preferred">Anemia</ElementValue>
                </Name>
              </Trait>
              <Comment>NTDT or non severe type of Thalassemia . Variant was found in a 6 year old girl suffering with anemia. coinherited with another deletion variant in HBD-HBB genomic region. Base line hemoglobin level of 10.7 g/dl. Due to the coinheritance of both allele deletion in HBB and HBD genomic region HbA2 is 0 % and maximum hemoglobin is HbF 96.5%.</Comment>
            </TraitSet>
            <Comment>Evidence 1: The variant was identified by target NGS analysis of entire beta globin gene cluster approximately 80.4 kb region on the short arm of chromosome 11, The deletion variant (3'-HBB-HBD-HBG1-HBG2-HBE1-5') was found in a thalassemia patient in compound heterozygous condition with another deletion mutation in (3'-HBB-HBD-5') genomic region . Due to common region of deletion in both alleles there was no sequence reads in HBB-HBD genomic region . Evidence 2: A long stretch of homozygous variant was identified from coordinate ( 5235201 - 5269140) of 33939 bp in variant calling file . Evidence 3: bioinformatic analysis by CNVkit, depthplot and finally IGV analysis shows no read in HBB-HBD region as well as low depth / low read count in the HBB-HBD-HBG1-HBG2-HBE1 genomic region as compare to the neighbouring genomic region. Evidence 4: PCR amplification of HBB gene was failed due to biallelic deletion</Comment>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh38" Chr="11" alternateAllele="-" innerStart="5235201" innerStop="5269140" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613985" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14582625</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9877402" TraitType="Disease" MappingType="XRef" MappingValue="613985" MappingRef="OMIM">
        <MedGen CUI="CN322236" Name="Beta-thalassemia HBB/LCRB" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9877402" TraitType="Finding" MappingType="Name" MappingValue="Anemia" MappingRef="Preferred">
        <MedGen CUI="C0002871" Name="Anemia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

